Avalo Therapeutics Inc (AVTX)
9.50
-0.14
(-1.45%)
USD |
NASDAQ |
May 17, 16:00
9.50
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Revenue (Annual): 1.924M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.924M |
| December 31, 2022 | 18.05M |
| December 31, 2021 | 5.398M |
| December 31, 2020 | 6.699M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.750M |
| December 31, 2018 | 7.028M |
| December 31, 2017 | 27.81M |
| December 31, 2016 | 1.153M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.924M
Minimum
2023
18.05M
Maximum
2022
7.764M
Average
6.699M
Median
2020
Revenue (Annual) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | 5.822M |
| Ocugen Inc | 6.036M |